Back
Apollo Global Management, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
53
APO
Apollo Global Management, Inc.
Last Price:
$147.20
Seasonality Move:
1.93%
Buy
75
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.62
Seasonality Move:
-5.43%
Buy
53
Apollo Global Management, Inc. (APO)
is a Buy
Is Apollo Global Management, Inc. a Buy, Sell or Hold?
-
The current Apollo Global Management, Inc. [APO] share price is $148.52. The Score for APO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
APO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APO Stock Price Chart
What is Apollo Global Management, Inc.'s stock price today?
-
The Apollo Global Management, Inc. share price today is $148.52The current trend is moderately bullish and APO is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight selling pressure.
APO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.54 | Buy |
| Relative Strength Index (14 RSI): | 68.27 | Buy |
| Chaikin Money Flow: | 24687 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (132.36 - 148.34) | Buy |
| Bollinger Bands (100): | (126.53 - 142.37) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.11 | Buy |
| Relative Strength Index (14 RSI): | 84.9 | Buy |
| Chaikin Money Flow: | -205319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.76 - 220.7) | Buy |
| Bollinger Bands (100): | (59.8 - 187.18) | Buy |
APO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 147.6 | Buy |
| 20-day SMA: | 143.05 | Buy |
| 50-day SMA: | 133.65 | Buy |
| 200-day SMA: | 135.87 | Buy |
| 8-day EMA: | 147.52 | Buy |
| 20-day EMA: | 143.46 | Buy |
| 50-day EMA: | 137.8 | Buy |
| 200-day EMA: | 136.64 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.61 | Buy |
| 20-day SMA: | 220.36 | Buy |
| 50-day SMA: | 170.63 | Buy |
| 200-day SMA: | 77.73 | Buy |
| 8-day EMA: | 220.58 | Buy |
| 20-day EMA: | 213.93 | Buy |
| 50-day EMA: | 180.36 | Buy |
| 200-day EMA: | 99.48 | Buy |
Apollo Global Management, Inc. Earnings Growth & APO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.27 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Apollo Global Management, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||